Placeholder

Index

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Thought leaders Featured in the bonus digital articles

Julian Adams, Ph.D. President, Research and ­Development and Chief Scientific Officer, Infinity ­Pharmaceuticals Inc.
Brent Ahrens. General Partner, Canaan Partners
Kenneth C. Aldrich. CEO, Chairman, and Co-Founder, ­International Stem Cell Corp.
Meryl Allison. Principal, Deloitte Consulting
Karla Anderson. Managing Director, Pharmaceuticals and Life-Sciences, Advisory Services Group, PricewaterhouseCoopers
Kelly Andrews. Director, Strategic Planning, MicroMass
Sam Azoulay. Senior VP, Medical & Development, Emerging ­Markets Business Unit, Pfizer Inc.
Jeff Baker. President and CEO, Noble ­Marketing Group
Joseph Baron. Partner, Extera Partners
Greg Barrett. VP of Marketing, Daiichi Sankyo
Nancy Beesley. Executive VP, Client ­Services, HC&B Healthcare ­Communications
Tim Bertram, D.V.M., Ph.D. Senior VP, Science and Technology, Tengion
Wendy Blackburn. Executive VP, Intouch ­Solutions
Chris Bode, Ph.D. VP, Corporate Development, ­Absorption ­Systems LP
Paul Boni. Chief Research Officer, Grail Research
Katrine Bosley. CEO, Avila Therapeutics Inc.
Jesse Bowden. President, Imaging Services, Biomedical Systems
Bonnie Brescia. Founding Principal, BBK Worldwide
Patrick Brundage. Practice Leader, Enterprise ­Analytics ­Practice, Cognizant
Carolyn Buck Luce. Global Pharmaceutical ­Leader, Ernst & Young
Neil Campbell. Chairman and CEO, Mosaigen
Faruk Capan. CEO, Intouch Solutions
Jay Carter. Senior VP, Director of Client Services, ­AbelsonTaylor
Bob Celeste. Director, GS1 Healthcare US
Sam Chakraborty. Senior Director, SSA & Co.
Michael N. Chang, Ph.D. President and CEO, Optimer ­Pharmaceuticals Inc.
Tony Chant. Managing Director, Eurocom Healthcare ­Communications
Dave Chapman. Managing Partner, ­CommonHealth
Todd Clark. President, Value of Insight ­Consulting Inc.
Patrick Collins. President, 5th Finger
Nick Colucci. President and CEO, Publicis ­Healthcare ­Communications Group
Terri Cooper, Ph.D. Principal, Deloitte ­Consulting LLP
Ben Currie. Emerging Technologies, Purohit Navigation
Lisa Davis. VP, Corporate Communications, AstraZeneca US
Jim Dayton. Emerging Media Director, Intouch Solutions
Evan Demesthas, M.D., R.PH. CEO, The Medical Affairs ­Company
Phil Deschamps. CEO and President, GSW Worldwide
Robert Dickinson. Client Service Officer, Life Sciences Practice, Grail Research
Paul Dreyer. Chief Commercial Strategist, Friday ­Morning
Matthew Eberhart. Global Business ­Development Leader, Quintiles Consulting
Todd Everhart, M.D., FACP. Director, Medical Affairs, Americas, Chiltern
Karen Ferrante, M.D. Senior VP, Clinical, ­Millennium: The ­Takeda Oncology Company
Astrid Frank. General Manager, Fisher Clinical Services
Laurie Halloran. President and CEO, Halloran ­Consulting Group
Michael J. Harte. Founder and President, Harte Group
Simon Higginbotham. Senior VP and Chief Marketing Officer, Kendle
Terry Hisey. Vice ­Chairman and U.S. Industry Leader, Life ­Sciences Practice, Deloitte LLP
Bill Hook. VP of Global Strategy, Healthcare ­Logistics, UPS Supply Chain Solutions
A. Shabeer Hussain. Programme Leader, ­Pharmaceutical and ­Biotechnology, Healthcare, EIA, Frost & Sullivan
Jason Hwang, M.D. Executive Director, ­Healthcare, Innosight Institute
Jim Jenson, Ph.D. CEO, Dicerna Pharmaceuticals
Jan-Anders Karlsson, Ph.D. CEO of S*BIO Pte Ltd.
Liz Kay. VP, Account Service, Cramer
Rick Keefer. President and CEO, Publicis ­Strategic ­Solutions Group
Greg Kirsch. VP, Creative ­Services of Intouch Solutions
Ryo Kubota, M.D., Ph.D. Chairman, President, and CEO, Acucela
Michael J. Laferrera. Senior VP, Sales and ­Marketing, J. Knipper & Co. Inc.
Nicholas Landekic. President and CEO, ­PolyMedix Inc.
Ilyssa Levins. President and Founder, Center for ­Communication ­Compliance
Kim Levy. Senior VP, MicroMass Communications
Patrick Lindsay. Executive VP, United BioSource Corp.
Nancy Lurker. CEO, PDI Inc.
Alistair Macdonald. Executive VP, Global ­Services, INC Research
John MacPhee. President, Strativa ­Pharmaceuticals
John Maraganore, Ph.D. CEO, Alnylam ­Pharmaceuticals
JeanMarie Markham. Founder and President, Clinlogix Inc.
Rudiger Mees. CEO, Unithink
David Merkel. Senior VP, Business Solutions, J. Knipper & Co. Inc.
Sylvia Miriyam Findlay. Programme Leader, ­Pharmaceutical and Biotechnology, Healthcare, Europe, at Frost & Sullivan
Celeste Mosby. VP, Life Sciences, Wilson Learning ­Worldwide
Mike Myers. President, Palio
Rajesh Nair, MMS, MBA. President and CEO, Indegene
Peter Nalen. CEO, Compass Healthcare Communications
Steven Nichtberger, M.D. President and CEO, Tengion
Lance Nickens. President, The Patient Recruiting Agency
Terry Nugent. VP Marketing, Medical ­Marketing Service
Michael O’Connell. Director of Life Sciences, Tibco ­Spotfire Inc.
Dave Ormesher. CEO, Closerlook Inc.
Sanjay Parikh, Ph.D. Director, Indegene
Stuart Peltz, Ph.D. CEO, PTC Therapeutics
Adelene Perkins. President and Chief ­Business Officer, Infinity Pharmaceuticals Inc.
Joseph Pieroni. President and CEO, Daiichi Sankyo Inc.
Vinod Podichetty, M.D., MS. Chief Scientific Advisor, Research Practice Partners Inc.
Richard F. Pops. Chairman, President, and CEO, Alkermes Inc.
John Potthoff, Ph.D. Chief Operating Officer, INC Research
Beth Price. Executive VP, The Medical Affairs ­Company
Ahnal Purohit, Ph.D. President and CEO, Purohit ­Navigation
Mark J. Pykett, V.M.D, MBA. President and Chief Operating ­Officer, Alseres Pharmaceuticals
Louis Renzetti, Ph.D. VP and Global Head, RNA ­Therapeutics, Roche
Ken Ribotsky. President and CEO, The Core Nation Inc.
Rick Rosenthal. Principal and Practice Leader, Sales Force ­Effectiveness, Health ­Strategies Group
Tom Russell. General Manager of ­Enterprise Solutions, SciQuest Inc.
Mike Rutstein. Founder and President, StrikeForce ­Communications LLC
Ed Sellers, M.D., Ph.D. VP, Early Stage, Kendle
Bob Silvers. Managing Director, SSA & Co.
Stephen M. Simes. President and CEO, BioSante ­Pharmaceuticals
Raj Singh. VP, General Manager, Formedic
Te Smith. VP, ­Communications,­ MarkMonitor
Nagaraja Srivatsan. Head of Life Sciences, North ­America, ­Cognizant Technology Solutions
Tom Steinke. CEO, Minnow Medical Inc.
Mark Stejbach. VP and Chief ­Commercial Officer, Tengion
Jeff Stomberg. CEO, Delta Pharma
Jason Stowe. CEO, Cycle Computing
Scott Treiber, Ph.D. Executive VP, Clinical ­Development Solutions, inVentiv Clinical Solutions
Mark Weinstein. CEO, BioClinica Inc.
James R. Weston. Senior VP, Talaris Advisors LLC
Mike Wexler. Principal, Biltmore Technologies
Roger L. Williams, M.D. CEO, U.S. Pharmacopeial Convention
Dave Womelsdorf. Americas Advisory Leader, Life Sciences, Ernst & Young
Steve Worland. President and CEO, Anadys ­Pharmaceuticals
Donna Wray. Management Advisor, TGaS Advisors
Steve Wunker. Senior Partner, Innosight
Claire R. Wynters. Business Development Associate, ­Criterium Inc.
Kleanthis Xanthopoulos, Ph.D. President and CEO, Regulus ­Therapeutics
Daniel Zurr, Ph.D. CEO and President, Quark ­Pharmaceuticals Inc.

FEEDBACK